Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging

Magnetic Resonance in Medicine

Volumn 39, Issue 5, 1998, Pages 813-824

  Abramovitch, Rinat ^a   Frenkiel, Daphna ^a   Neeman, Michal ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Angiogenesis; Blood oxygenation; Neovascularization; Vascular function

Indexed keywords

BLOOD; MAGNETIC RESONANCE IMAGING; MAMMALS; MICROCIRCULATION; TISSUE REGENERATION;

ANGIOGENESIS; ANGIOGENIC GROWTH FACTORS; ANTIANGIOGENIC AGENT; BLOOD OXYGENATION; MULTICELLULAR TUMOR SPHEROIDS; NEO-VASCULARIZATION; NONINVASIVE ANALYSIS; VASCULAR FUNCTIONS;

BLOOD VESSELS;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BLOOD OXYGENATION; CANCER; CANCER RESEARCH; DIAGNOSTIC IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; TUMOR BLOOD FLOW;

EID: 0031969258     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.1910390519     Document Type: Article

References (46)

1. D. Knighton, D. Ausprunk, D. Tapper, J. Folkman, Avascular and vascular phases of tumor growth in the chick embryo. Br. J. Cancer 35, 347-356 (1977).
2. M. A. Gimbrone, Jr., R. S. Cotran, S. B. Leapman, J. Folkman, Tumor growth and neovascularization: an experimental model using the rabbit cornea. J. Natl. Cancer Inst. 52, 413-427 (1974).
3. M. Greenblatt, P. Shubik, Tumor angiogenesis: transfilter diffusion studies in the hamster by the transparent chamber technique. J. Nat. Cancer Inst. 41, 111-124 (1968).
4. M. Neeman, Assessment of angiogenesis by MRI, in "NATO ASI: Angiogenesis: Models, Modulators, and Clinical Applications" (M. Maragoudakis, Ed.), Plenum, New York, 1997.
5. R. Brasch, C. Pham, D. Shames, T. Roberts, K. van-Dijke, N. van-Bruggen, J. Mann, S. Ostrowitzki, O. Melnyk, Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J. Magn. Reson. Imaging 7, 68-74 (1997).
6. J. Dennie, J. B. Mandeville, R. M. Weisskoff, B. R. Rosen, Quantitative imaging of tumor angiogenesis, in "Proc., ISMRM, 5th Annual Meeting, Vancouver, B.C., Canada, 1997," p. 489.
7. E. Furman-Haran, R. Margalit, D. Grobgeld, H. Degani, Dynamic contrast-enhanced magnetic resonance imaging reveals stress-induced angiogenesis in MCF7 human breast tumors. Proc. Natl. Acad. Sci. U S A 93, 6247-6251 (1996).
8. 3 targeted magnetic resonance imaging, in "Proc., ISMRM, 5th Annual Meeting, Vancouver, B.C., Canada, 1997," p. 334.
9. R. Abramovitch, G. Meir, M. Neeman, Neovascularization-induced growth of implanted C6 glioma multicellular spheroids: magnetic resonance microimaging. Cancer Res. 55, 1956-1962 (1995).
10. S. Ogawa ,T. M. Lee, Magnetic resonance imaging of blood vessels at high fields: in vivo and in vitro measurements and image simulation. Magn. Reson. Med. 16, 9-18 (1990).
11. S. Ogawa, T. M. Lee, A. S. Nayak, P. Glynn, Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn. Reson. Med. 14, 68-78 (1990).
12. S. Ogawa, R. S. Menon, D. W. Tank, S. G. Kim, H. Merkle, J. M. Ellermann, K. U 151 urbil, Functional brain mapping by blood oxygenation level-dependent contrast magnetic resonance imaging. A comparison of signal characteristics with a biophysical model. Biophys. J. 64, 803-812 (1993).
13. S. Ogawa, T. M. Lee, B. Barrere, The sensitivity of magnetic resonance image signals of a rat brain to changes in the cerebral venous blood oxygenation. Magn. Reson. Med. 29, 205-210 (1993).
14. P. A. Bandettini, E. C. Wong, R. S. Hinks, R. S. Tikofsky, J. S. Hyde, Time course EPI of human brain function during task activation. Magn. Reson. Med. 25, 390-397 (1992).
15. S. Ogawa, D. W. Tank, R. Menon, J. M. Ellermann, S. G. Kim, H. Merkle, K. U 151 urbil, Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging. Proc. Natl. Acad. Sci. U S A 89, 5951-5955 (1992).
16. K. K. Kwong, J. W. Belliveau, D. A. Chesler, I. E. Goldberg, R. M. Weisskoff, B. P. Poncelet, D. N. Kennedy, B. E. Hoppel, M. S. Cohen, R. Turner, H. M. Cheng, T. J. Brady, B. R. Rosen, Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc. Natl. Acad. Sci. U S A 89, 5675-5679 (1992).
17. I. P. Torres Filho, M. Leunig, F. Yuan, M. Intaglietta, R. K. Jain, Noninvasive measurement of microvascular and interstitial oxygen profiles in a human tumor in SCID mice. Proc. Natl. Acad. Sci. U S A 91, 2081-2085 (1994).
18. M. E. Meyer, O. Yu, B. Eclancher, D. Grucker, J. Chambron, NMR relaxation rates and blood oxygenation level. Magn. Reson. Med. 34, 234-241 (1995).
19. M. Dellian, B. P. Witwer, H. A. Salehi, F. Yuan, R. K. Jain, Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment. Am. J. Pathol. 149, 59-71 (1996).
20. S. Runkel, N. Hunter, L. Milas, An intradermal assay for quantification and kinetics studies of tumor angiogenesis in mice. Radiat. Res. 126, 237-243 (1991).
21. A. Passaniti, R. M. Taylor, R. Pili, Y. Guo, P. V. Long, J. A. Haney, R. R. Pauly, D. S. Grant, G. R. Martin, A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest. 67, 519-528 (1992).
22. L. E. Benjamin, E. Keshet, Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc. Natl. Acad. Sci. USA 94, 8761-8766 (1997).
23. E. K. Rofstad, R. M. Sutherland, Growth and radiation sensitivity of the MLS human ovarian carcinoma cell line grown as multicellular spheroids and xenografted tumors. Br. J. Cancer 59, 28-35 (1989).
24. Y. S. Schiffenbauer, R. Abramovitch, G. Meir, N. Nevo, M. Holzinger, A. Itin, E. Keshet, M. Neeman, Loss of ovarian function promotes angiogenesis in human ovarian carcinoma Proc. Natl. Acad. Sci. USA 94, 13203-13208 (1997).
25. E. K. Rofstad, Orthotopic human melanoma xenograft model systems for studies of tumor angiogenesis, pathophysiology, treatment sensitivity, and metastatic pattern. Br. J. Cancer 70, 804-812 (1994).
26. 2H nuclear magnetic resonance studies. Cancer Res. 51, 3289-3295 (1991).
27. H. F. Dvorak, V. S. Harvey, P. Estrella, L. F. Brown, J. McDonagh, A. M. Dvorak, Fibrin-containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab. Invest. 57, 673-686 (1987).
28. J. Ellermann, M. Garwood, K. Hendrich, R. Hinke, X. Hu, S. Kim, R. Menon, H. Merkle, S. Ogawa, K. U 151 urbil. Functional imaging of the brain by nuclear magnetic resonance, in "NMR in Physiology and Biomedicine" (R. J. Gillies, Ed.), p. 137-150, Academic Press, New York, 1994.
29. S. A. Skinner, P. J. Tutton, P. E. O'Brien, Microvascular architecture of experimental colon tumors in the rat. Cancer Res. 50, 2411-2417 (1990).
30. S. P. Robinson, F. A. Howe, J. R. Griffiths, Noninvasive monitoring of carbogen-induced changes in tumor blood flow and oxygenation by functional magnetic resonance imaging. Int. J. Radiat. Oncol. Biol. Phys. 33, 855-859 (1995).
31. 2* and resonance frequency weighted magnetic resonance images of rodent tumors. NMR Biomed. 7, 3-11 (1994).
32. M. K. Klagsbrun, J. Folkman, Angiogenesis, in "Peptide Growth Factors and Their Receptors" (M. B. Sporn, A. B. Roberts, Eds.), Vol. 2, pp. 549-588, Springer-Verlag New York Inc., New York, 1991.
33. S. P. Robinson, M. G. Kuchel, A. S. E. Ojugo, P. M. J. McSheehy, F. A. Howe, J. R. Griffiths, The response to carbogen breathing of tumors grown in nude mice monitored by gradient-recalled echo magnetic resonance imaging, in "Proc., ISMRM, 4th Annual Meeting, New York, 1996," p. 1105.
34. D. Hanahan, J. Folkman, Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 88, 353-364 (1996).
35. R. Abramovitch, M. Marikovsky, G. Meir, M. Neeman, Stimulation of tumor angiogenesis by proximal wounds: spatial and temporal analysis by MRI. Br. J. Cancer, in press.
36. D. Shweiki, A. Itin, D. Soffer, E. Keshet, Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843-845 (1992).
37. D. Shweiki, M. Neeman, A. Itin, E. Keshet, Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc. Natl. Acad. Sci. USA 92, 768-772 (1995).
38. I. Stein, M. Neeman, D. Shweiki, A. Itin, E. Keshet, Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol. Cell. Biol 15, 5363-5368 (1995).
39. L. F. Brown, K. T. Yeo, B. Berse, T. K. Yeo, D. R. Senger, H. F. Dvorak, L. van de Water, Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J. Exp. Med. 176, 1375-1379 (1992).
40. H. Menke, P. Vaupel, Effect of injectable or inhalational anesthetics and of neuroleptic, neuroleptanalgesic, and sedative agents on tumor blood flow. Radiat. Res. 114, 64-76 (1988).
41. 31P NMR spectra in murine RIF-1 tumors. Magn. Reson. Med. 33, 610-618 (1995).
42. M. Y. Su, J. C. Jao, O. Nalcioglu, Measurement of vascular volume fraction and blood-tissue permeability constants with a pharmacokinetic model: studies in rat muscle tumors with dynamic Gd-DTPA enhanced MRI. Magn. Reson. Med. 32, 714-724 (1994).
43. H. F. Dvorak, L. F. Brown, M. Detmar, A. M. Dvorak, Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146, 1029-1039 (1995).
44. 2*-weighted images during hyperoxia differentiate tumors from normal tissue. Magn. Reson. Med. 33, 318-325 (1995).
45. J. H. Kaanders, L. A. Pop, H. A. Marres, R. W. van der Maazen, A. J. van der Kogel, W. A. van Daal, Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicity. Radiother. Oncol. 37, 190-198 (1995).
46. A. Rojas, V. K. Hirst, A. S. Calvert, H. Johns, Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 34, 357-365 (1996).